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The nucleolus is the center of ribosome synthesis, with the nucleophosmin (NPM) and p19ARF proteins
antagonizing one another to either promote or inhibit growth. However, basal NPM and ARF proteins form
nucleolar complexes whose functions remain unknown. Nucleoli from Arf/ cells displayed increased nucle-
olar area, suggesting that basal ARF might regulate key nucleolar functions. Concordantly, ribosome biogen-
esis and protein synthesis were dramatically elevated in the absence of Arf, causing these cells to exhibit
tremendous gains in protein amounts and increases in cell volume. The transcription of ribosomal DNA
(rDNA), the processing of nascent rRNA molecules, and the nuclear export of ribosomes were all increased in
the absence of ARF. Similar results were obtained using targeted lentiviral RNA interference of ARF in
wild-type MEFs. Postmitotic osteoclasts from Arf-null mice exhibited hyperactivity in vitro and in vivo,
demonstrating a physiological function for basal ARF. Moreover, the knockdown of NPM blocked the increases
in Arf/ ribosome output and osteoclast activity, demonstrating that these gains require NPM. Thus, basal
ARF proteins act as a monitor of steady-state ribosome biogenesis and growth independent of their ability to
prevent unwarranted hyperproliferation.
Cellular growth (i.e., macromolecular synthesis) is an essen-
tial function during the early parts of the cell cycle. For cells to
transit the G1 restriction point, they must duplicate nearly their
entire protein content; failure to do so would result in smaller
daughter cells (12). Only recently has an emphasis been placed
on the fundamental control of cell growth and its link to the
cell cycle. Developments in the understanding of how the cell
senses environmental nutritional cues has led to a flurry of
research on understanding the mechanisms underlying growth
control (40). Not surprisingly, several of these pathways con-
verge on the synthesis of new ribosomes in the cell nucleolus
and the regulation of translation.
Approximately half of the cell’s energy expenditure is di-
rected toward ribosome biogenesis (26). The nucleolus, long
recognized as a marker for active cellular growth, was first
described in the early 1960s as the center of ribosomal DNA
(rDNA) transcription and ribosome biogenesis (6, 32). This
organelle is composed of three regions, on the basis of mor-
phology at the ultrastructural level: the fibrillar centers, the
dense fibrillar compartment, and the granular zone. rDNA
transcription occurs in the junction region between the fibrillar
centers and the surrounding dense fibrillar component, and the
resulting rRNA is further processed in the periphery of the
dense fibrillar component. Further posttranscriptional modifi-
cations and assembly into subunits occur in the surrounding
granular region (18).
While the primary mechanisms regulating these processes
have been well studied in Saccharomyces cerevisiae (13), mul-
ticellular organisms demand more complex regulatory mecha-
nisms, in that proliferative capacity is determined not only by
the relative abundance of nutrients but also by complicated
extracellular signals and growth factors. Indeed, previous stud-
ies have demonstrated convergence between the growth and
the proliferation pathways via regulation of the tumor suppres-
sor gene products Rb and p53 (9, 17, 43, 48). Both products are
known to negatively regulate the activity of polymerase I in
rDNA transcription. Oncogenes such as c-Myc also regulate
the transcription of rDNA and the genes that encode ribo-
somal proteins, implying that an intricate network exists within
the nucleolus to ensure the proper synthesis of ribosomes (7,
15, 16).
The tumor suppressor p19ARF represents an attractive can-
didate for coupling proliferation to growth. Given its nucleolar
localization (39, 44, 45) and potent induction by hyperprolif-
erative signals (19, 20, 31, 50), ARF represents a potential
nucleolar integrator of growth signals coming into the cell. It
has been regarded classically as an activator of p53 through its
ability to sequester Mdm2, the E3 ubiquitin ligase for p53, in
the nucleolus (39, 44, 45). However, recent data have demon-
strated a role for ARF in binding to and affecting the function
of the ribosomal chaperone nucleophosmin (NPM), indepen-
dent of its ability to regulate p53 (4, 8, 21). Furthermore, these
data are consistent with those from a growing number of stud-
ies with mice and humans that describe p53-independent func-
tions for ARF tumor suppression (35).
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Given ARF’s nucleolar localization, its role in suppressing
cellular growth and proliferation, and its ability to bind to a
protein involved in ribosome biogenesis, we were inclined to
explore the functional and physiological consequences of ARF
disruption of growth and ribosome biogenesis. Through in
vitro and in vivo assays, we utilized targeted Arf knockout mice
and selective ARF knockdown via lentiviral RNA interference.
Cells derived from Arf-null mice displayed significant alter-
ations in gross nucleolar morphology and abundance and had
a marked increase in basal protein synthesis levels compared to
that in wild-type cells. Furthermore, this increase in protein
synthesis was correlated to increased ribosome biogenesis and
cytoplasmic ribosome content, implying a regulatory role for
ARF in these processes. Importantly, though ARF levels are
nearly undetectable in low-passage mouse embryonic fibro-
blasts (19), the knockdown of endogenous ARF via short hair-
pin RNA (shRNA) constructs mimicked the Arf-null nucleolar
and ribosomal phenotype, implying an important ribosome
homeostatic role for basal ARF proteins in wild-type cells. The
progrowth phenotype of the Arf loss was not limited to prolif-
erating cells, as fully differentiated osteoclasts from Arf-null
mice exhibited tremendous gains in protein synthesis and over-
all activity in vivo. Mechanistically, all of the ribosome gains
exhibited by the loss of Arf were reversed by the removal of the
nucleolar NPM proto-oncogene, indicating that NPM, when
untethered from ARF, promotes unrestrained ribosome bio-
genesis. Taken together, these data strongly argue for a mo-
ment-to-moment “thermostat”-like role for basal ARF mole-
cules in controlling NPM-directed ribosome biogenesis and
protein synthetic rates.
MATERIALS AND METHODS
Mice. Arf/ mice were rederived from triple-knockout heterozygous mice
(Arf/Mdm2/ p53/; a generous gift from G. Zambetti, St. Jude, Memphis,
TN) to a pure C57BL/6 background by several generations of backcrosses to
wild-type C57BL/6 mice, followed by breeding to homozygosity. Age-matched
wild-type C57BL/6 littermates were used as controls where indicated. Organs
were harvested from mice 4 days postnatally.
Cell culture, reagents, and antibodies. Low-passage (2–5) MEFs were isolated
and maintained in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum, 10 g/ml gentamicin, 1 nonessential amino acids, 1 mM
sodium pyruvate, and 2 mM glutamine. Rabbit anti-p16INK4A (sc-1207), goat
anti--tubulin (catalog no. sc-7396), and rabbit anti-Myc (catalog no. sc-764)
were purchased from Santa Cruz Biotechnology. Rat anti-p19ARF (catalog no.
NB 200-169A) was purchased from Novus Biologicals. Mouse anti-NPM (catalog
no. 32-5200) was purchased from Zymed.
Plasmid constructs. pLKO-GFP, a lentiviral shRNA expression vector was a
generous gift from Sheila Stewart (Washington University). To construct the
ARF shRNA vector, pLKO-GFP was digested with AgeI/MluI, and annealed
oligonucleotides containing the shRNA target (nucleotides 157 to 177 of exon 1
of p19ARF) or a scrambled control were cloned into these sites. The resultant
clones were verified by sequencing. The oligonucleotides used were small inter-
fering ARF (siARF) sense (5-CCGGGCTCTGGCTTTCGTGAACATGCTCG
AGCATGTTCACGAAAGCCAGAGCTTTTTA-3), siARF antisense (5-CGC
GTAAAAAGCTCTGGCTTTCGTGAACATGCTCGAG CATGTTCACGAA
AGCCAGAGC-3), siScrambled sense (5-CCGGTACG ACCTGAACTGCTTA
GGACTCGAGTCCTAAGCAGTTCAGGTCGTATTTTTA-3), and siScrambled
antisense (5-CGCGTAAAAATACGACCTGAACTGCTTAGGACTCGAGTC
CTAAGCAGTTCAGGTCGTA-3). The underlined portions represent the 21
nucleotide hairpin sense and antisense strands. For NPM knockdown, annealed
oligonucleotides were cloned as described above into pLKO-GFP, the sequences
of which were previously reported (27). RNA interference for endogenous c-Myc
was performed with siRNAs recognizing the 3 untranslated region (UTR) of
c-Myc (5-AACGTTTATAACAGTTACAAA-3 [Qiagen]). Myc-ER retrovirus
was generated and used to infect wild-type and Arf-null MEFs as previously
described (50).
AgNOR staining. MEFs were seeded onto glass coverslips overnight and were
fixed and stained the following day. A silver nucleolar organizing region
(AgNOR) staining method was modified from the protocol presented by Aubele
et al. (1). Briefly, cells were fixed in 2% glutaraldehyde, followed by a postfixation
in a 3:1 ethanol-acetic acid solution. Cells were stained with a 0.33% formic
acid-33.3% silver nitrate solution in 0.66% gelatin and mounted on slides with
Vectashield (Vector Labs).
Histomorphometry. Histomorphometric analysis was performed with Osteo-
Quant Nova Prime software (Bioquant Image Analysis Corp.) on images cap-
tured at 200 magnification by an Optitronics Magnifire camera on a Nikon
TE300 microscope. Total numbers and total areas (m2) of AgNOR regions per
nucleus from 100 nuclei were assessed, and statistical significance was deter-
mined using Student’s t test.
Electron microscopy. Asynchronously growing wild-type and Arf/ MEFs
were trypsinized and fixed with 2% glutaraldehyde in phosphate-buffered saline
for 10 min. Samples were further processed by the Washington University De-
partment of Cell Biology’s Electron Microscopy Core. Pictures of nuclei and
nucleoli were taken at magnifications of 3,000 and 7,000, respectively.
[35S]methionine incorporation assay. Cells (1  105) were seeded in triplicate
and then starved of methionine and cysteine. Cells were pulsed with 14.3 Ci of
[35S]methionine (Amersham) and then immediately washed twice with cold
phosphate-buffered saline and lysed with 1% Triton X-100 buffer. Total protein
was precipitated from lysates with 10% trichloroacetic acid. Pellets were sub-
jected to liquid scintillation counting to measure the incorporated counts per
minute.
Ribosome fractionation. Cells (2  106) were treated with 50 g/ml cyclohex-
imide prior to trypsinization and lysis, and fractionation was carried out over a 10
to 45% sucrose gradient (46). Gradients were fractionated, and RNA absorbance
at 254 nm was monitored continuously to detect ribosomal subunits.
Lentiviral production and infection. 293T cells (5 105) were transfected with
1 g of pLKO-GFP containing either scrambled or ARF shRNA cassettes along
with the pHR8.2R packaging vector and the pCMV-VSV-G envelope vector.
Viral supernatants were collected and pooled. Wild-type MEFs (8  105) were
plated and infected with viral supernatant containing 10 g/ml protamine sulfate.
Cells were infected again on the following day, checked for green fluorescent
protein expression, and allowed to express the shRNA construct for 48 h.
Serum assays. Levels of tartrate-resistant acid phosphatase (TRAP) 5b were
measured in serum collected from wild-type or Arf/ mice, using a TRAP 5b
enzyme-linked immunosorbent assay (ELISA) system (IDS, Fountain Hills, AZ).
Osteoclast formation assays. Whole bone marrow was extracted from femurs
and tibias of wild-type or Arf/ mice and plated in CMG-14-12 culture super-
natant (1/10 vol) in 	-minimal essential medium (	-MEM) containing 10% fetal
calf serum (FCS) to generate primary bone marrow macrophages (BMM), as
described previously (49). Cells were fed every day with 	-MEM containing 10%
FCS, CMG-14-12 supernatant (1/20 vol), and glutathione S-transferase-RANK
ligand (GST-RANKL) (100 ng/ml) and incubated for 5 days to generate osteo-
clasts (49). TRAP staining was performed according to the manufacturer’s in-
structions (Sigma-Aldrich, St. Louis, MO). Five fields at a magnification of 4
were captured with the Magnafire system, and the TRAP-positive cells with three
or more nuclei were counted by one blinded to the genotype. A quantitative
TRAP solution assay was performed by adding a colorimetric substrate, 5.5 mM
p-nitrophenyl phosphate, in the presence of 10 mM sodium tartrate at pH 4.5.
Macrophage proliferation assays. BMMs (1  104) were plated in 	-MEM
containing 10% FCS and CMG-14-12 supernatant (1/10 vol). Cells were starved
in 	-MEM containing 0.1% FCS for 12 h. At this time, 	-MEM containing 10%
FCS and CMG-14-12 supernatant (1/10 vol) was added back to the cells. Cells
were labeled with bromodeoxyuridine (BrdU) for 24 h, and proliferation was
measured using the chemiluminescent cell proliferation ELISA (Roche Diag-
nostics, Mannheim, Germany).
Western blotting and serial immunoprecipitation. MEF cell extracts (30 g)
were loaded onto 4 to 20% sodium dodecyl sulfate (SDS)-polyacrylamide gels
(ISC Biosciences), transferred to polyvinylidene difluoride membrane (Milli-
pore), and probed with antibody to rat anti-p19ARF (Novus Biologicals), goat
anti--tubulin (Santa Cruz Biotechnology), rabbit anti-Myc (Santa Cruz Biotech-
nology), rabbit anti-p16INK4A (Santa Cruz Biotechnology), and rabbit anti-L5
(ILAMM). Secondary horseradish peroxidase-conjugated anti-rabbit, anti-goat,
or anti-rat antibodies (Jackson ImmunoResearch) and ECL (Amersham) were
used to visualize the bands. For serial immunoprecipitation, 200 g of wild-type
MEF lysate was immunoprecipitated with GammaBind (Amersham) by a cus-
tom-made rabbit NPM polyclonal antibody (Sigma Genosys) (46). The final
supernatant was concentrated with a Vivaspin column (Vivascience), and all
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samples were loaded onto 10% SDS-polyacrylamide gels for immunoblotting
analysis.
47S rRNA real-time reverse transcription-PCR. Levels of 47S rRNA tran-
scripts were determined as described previously by Cui and Tseng (10). Briefly,
total RNA was reverse transcribed with a mouse rRNA-specific primer (5-CG
TGGCATGAACACTTGG-3). Real-time PCR was performed with iQ SYBR
Green Supermix (Bio-Rad) according to the manufacturer’s protocol, with the
forward primer 5-CTGACACGCTGTCCTTTCCC-3 and the reverse primer
5-GTGAGCCGAAATAAGGTGGC-3 on an iCycler thermal cycler (Bio-
Rad). The absolute copy number was obtained by comparison to serial dilutions
of a known amount of plasmid containing the mouse rDNA repeat.
rRNA labeling experiments. Equal numbers of wild-type and Arf/ MEFs
were starved in methionine-free media containing 10% dialyzed fetal bovine
serum. For uridine labeling, cells were labeled in medium containing 2.5 Ci/ml
[3H]uridine (Amersham) and then chased in label-free medium. Where noted,
cells were treated with 50 Ci/ml [methyl-3H]methionine (Amersham) for 30 min
and chased in unlabeled methionine-containing (10 M) media in the nuclear/
cytoplasmic fractionation experiments. Total RNA was isolated using Trizol
reagent (Invitrogen) and loaded onto 1% agarose-formaldehyde gels for the
uridine experiments. Cellular fractionation was carried out using a nuclear ex-
traction kit according to the manufacturer’s protocol (Active Motif). Total RNA
was isolated from the nuclear and cytoplasmic fractions using Trizol and loaded
onto 1% agarose-formaldehyde gels. RNA was transferred to Hybond N mem-
branes (Amersham), cross-linked, sprayed with En3Hance (Perkin-Elmer), and
subjected to autoradiography.
RESULTS
p19ARF is required for proper nucleolar morphology. A
common theme in ARF biology is its intrinsic localization
within the nucleolus, under both basal and oncogene-induced
settings (31, 39, 44, 45). Many of ARF’s binding partners either
reside in the nucleolus or are relocalized there by ARF itself
(25, 35). Of the resident nucleolar ARF binding proteins,
nearly all are involved in some facet of ribosome biogenesis
(e.g., transcription, processing, or export) (34, 35). We hypoth-
esized that basal nucleolar ARF proteins, even at low levels,
might exert a subtle activity on these nucleolar proteins to
continuously monitor their function. To this end, we adapted
an AgNOR staining protocol (1) for use with MEFs derived
from wild-type and from Arf/ mice. Staining methods utiliz-
ing the reduction of silver on argyrophilic proteins surrounding
the nucleolar organizing region have been used for decades as
a prognostic factor with certain carcinomas, wherein increases
of the AgNOR index tend to correlate with poor prognoses
(28). AgNOR staining of Arf/ MEFs demonstrated mark-
edly higher numbers of AgNORs per nucleus and a distinctly
irregular shape than the numbers and the more rounded, sym-
metrical shape of the wild-type AgNOR counterparts (Fig.
1A). At the ultrastructural level, we also observed multiple,
elongated, irregular nucleoli in Arf/ cells compared to the
round nucleoli of the wild-type cells (Fig. 1B, top panels).
These irregularities in Arf-null cells were also associated with
larger fibrillar centers, the sites of rDNA transcription (Fig.
1B, bottom panel, arrows). We quantitated the total nucleolar
area per nucleus (a common pathological definition of the
AgNOR index) (42) and observed a 20% increase in Arf/
cells (31.6 m2 versus 26.4 m2; n
 100; P 0.001) (Fig. 1C).
A significant increase in the AgNOR number per nucleus was
also observed (5.78 versus 3.49; n 
 100; P  0.001). Addi-
tionally, nucleolar morphology changes were observed in vivo.
Intestine and liver tissues harvested from newborn wild-type
and Arf-null mice and stained for AgNORs recapitulated our
earlier in vitro findings in that the loss of Arf resulted in
dramatic gains in both AgNOR numbers and overall area (Fig.
2A and B). Moreover, we also observed a moderate increase in
the number of larger multinucleolar cells in the livers of Arf-
deficient mice (Fig. 2A, right panels). Taken together, these
data suggest a role for p19ARF in maintaining a proper nucle-
olar structure in vitro and in vivo.
Loss of Arf enhances protein synthesis and ribosome bio-
genesis independent of proliferation. The loss of Arf resulted
in dramatic alterations in nucleolar structure (Fig. 1 and 2),
suggesting that basal ARF may function in the maintenance of
this organelle. To determine whether changes in nucleolar
structure result in altered nucleolar function, we assessed
ribosome output from the nucleolus. First, we performed
[35S]methionine pulse-labeling experiments, measuring the
amount of radioactivity incorporated into newly translated
proteins over time. As shown, Arf/ MEFs had an approxi-
FIG. 1. Loss of ARF results in nucleolar morphological changes.
(A) AgNOR staining of representative wild-type (WT) and Arf/
MEFs. Increases in the number and irregularity of the AgNOR indices
in the Arf/ cells are shown. (B) Ultrastructural features of nuclei
from the wild-type and Arf/ MEFs. Arrows indicate nucleoli
(3,000) and fibrillar centers (7,000). (C) Quantification of
AgNOR indices from panel A. The left panel shows the number of
AgNORs per nucleus (n 
 100). The right panel shows the total
nucleolar area (in m2) per nucleus as determined by histomorpho-
metric analysis (n 
 100). , P  0.01.
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mately fourfold increase in incorporated [35S]methionine com-
pared to that of wild-type cells after 24 h (Fig. 3A). Further-
more, this increased protein synthesis was not related to any
increase in proliferation rates, as the proliferation of the low-
passage wild-type and the Arf/ MEFs was virtually identical
(Fig. 3B). To determine if the protein synthesis differences
were due to increased ribosomal output, we performed sucrose
density gradient rate-zonal ultracentrifugation of cytoplasmic
lysates from wild-type and Arf-null cells to separate ribosomes.
Ribosome subunits and actively translating polysomes were
identified by real-time monitoring of absorbance at 254 nm to
detect the relative amounts of ribosomal RNAs present in each
of the subunit fractions. Compared to the wild-type lysates,
lysates of the Arf/ cells had significantly more (nearly 40%)
cumulative absorbance in the actively translating polysome
fraction, indicating a relative abundance of these ribosomal
components (Fig. 3C). Consistent with gains in ribosome pro-
duction and protein synthesis, we observed a significant in-
crease in the overall volume of low-passage Arf-deficient MEFs
as well as a robust increase in protein content per cell (Fig. 3D
and E). Moreover, gains in ribosome biogenesis were also seen
in vivo. Livers were isolated from newborn wild-type and Arf-
null mice, minced, and immediately placed in [35S]methionine-
containing medium to measure protein synthesis rates. Cells
isolated from Arf-null livers exhibited a nearly 15-fold increase
in protein synthesis compared to that of the wild-type litter-
mates (Fig. 4A). Additionally, cells freshly isolated from
Arf/ mouse spleens also showed dramatic increases in 40S,
60S, and 80S and polysome content (Fig. 4B), demonstrating
elevated ribosome output in these tissues. We therefore pos-
tulated that basal ARF proteins might act as negative regula-
tors at a certain step(s) in nucleolar ribosome biogenesis.
The acute knockdown of ARF mimics the phenotype of
Arf/ cells. Since ARF’s role in sensing hyperproliferative
signals and concomitantly inducing p53-dependent cell cycle
arrest have been well established (19, 20, 31, 50), it has been
assumed that basal ARF has little, if any, function in the
normal day-to-day regulation of cellular homeostasis. How-
ever, ARF levels in asynchronously growing wild-type cells are
detectable by Western blotting analysis and immunohisto-
chemistry (5). Given our finding that Arf/ cells exhibit
chronic nucleolar morphology changes and increased ribosome
output (Fig. 1 to 4), we were poised to reexamine this question
in an acute setting by knocking down basal ARF in wild-type
cells. This was accomplished by using lentiviral constructs con-
taining a shRNA duplex that recognized bases 157 through 177
in the ARF-specific exon 1 of the Ink4a/Arf locus. To verify
the specificity of this construct, we infected wild-type MEFs
with lentivirus containing either shRNA specific to ARF or a
scrambled control sequence. As shown by Western blotting
analysis, infection with viruses containing the ARF shRNA
sequence produced a robust knockdown of the level of ARF
(96%) without decreasing levels of p16INK4A (Fig. 5A).
Moreover, expression of other nucleolar proteins, such as
NPM and ribosomal protein L5, also remained unchanged
following the ARF knockdown (Fig. 5A). As observed first
with the Arf/ MEFs, the ARF knockdown MEFs also exhib-
ited dramatic nucleolar morphology alterations as depicted by
AgNOR staining (Fig. 5B). These acute changes were of
greater statistical difference than those originally observed
with Arf-null cells, with a significant increase in both the num-
ber of AgNORs per nucleus (6.6 versus 3.3; n 
 100; P 
0.001) and the total AgNOR-stained area per nucleus (49.8
m2 versus 36.8 m2; n 
 100; P  0.001) (Fig. 5C). Similarly,
the ARF knockdown MEFs displayed tremendous gains in
protein synthesis rates as determined by [35S]methionine in-
corporation, nearly 10-fold higher than that of scrambled con-
trol MEFs (Fig. 5D) and almost twice as high as that of Arf-null
MEFs (compared to Fig. 3A). The ARF knockdown MEFS
also produced significantly more actively translating polysomes
(55% more) as determined by UV monitoring of cytosolic
rRNAs (Fig. 5E), suggesting that the acute loss of ARF has a
greater impact on nucleolar functions.
Genetic disruption of Arf results in increased osteoclast
numbers in vitro and elevated levels of TRAP protein in vitro
and in vivo. To demonstrate a physiological function for ARF’s
baseline regulation of ribosome biogenesis and protein synthe-
sis, we focused on bone-resorbing osteoclasts as a model of a
differentiated cell with high protein synthesis demands. Osteo-
clasts are formed by the fusion of hematopoietically derived
macrophages into multinucleated giant cells with a specialized
ruffled border containing thousands of vacuolar H-ATPases.
The osteoclast forms a sealing zone against the area of bone
resorption and, in doing so, allows the specialized ruffled mem-
brane to secrete collagenase and dramatically lower the pH
through the activity of the proton pumps. As a result, the
osteoclast has a high demand for protein synthesis, since the
H-ATPases are specific to the mature osteoclast and are not
FIG. 2. Tissues from newborn Arf/ mice display altered nucle-
olar morphology reminiscent of the in vitro findings. (A) AgNOR
staining of representative sections from the intestine and liver.
(B) Quantification of total AgNOR area per nucleus (n 
 100). *,
P  0.01. WT, wild type.
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found in macrophage precursors (41). Furthermore, since the
mature osteoclast is a postmitotic cell, it affords an excellent
opportunity to examine ARF’s effects on protein and ribosome
metabolism independent of proliferation.
We first determined whether the proliferation rates varied
between wild-type and Arf/ BMM, osteoclast precursors.
BrdU labeling of BMMs demonstrated no significant differ-
ences in the proliferation rates between wild-type and Arf/
osteoclast precursors (Fig. 6A), similar to the equal prolifera-
tion rates of early passage MEFs (Fig. 3B). Next, BMMs from
Arf/ and wild-type mice were induced to produce mature
osteoclasts by the addition of macrophage colony-stimulating
factor (M-CSF) and RANKL. After 3 days of stimulation with
RANKL, cells were fixed and stained with a TRAP substrate,
an osteoclast-specific stain that relies on the abundance of
TRAP protein produced by the osteoclast. An increased num-
ber of mature osteoclasts derived from the Arf/ precursors
was observed compared to that of the wild-type controls (Fig.
6B). TRAP-positive cells with greater than five nuclei were
counted as a way to differentiate maturing osteoclasts from
immature precursors and resulted in a significant increase in
the Arf/ genotype (149 versus 91 per well; n 
 5; P 
 0.01)
(Fig. 6C).
To determine if the differences seen with osteoclastogenesis
were functionally relevant, we compared the TRAP activities
(a marker of osteoclast function) of equal numbers of TRAP-
positive cells, as determined above. Cell lysates were incubated
from day 4 post-RANKL addition (for wild-type cells) and day
3 post-RANKL addition (for Arf/ cells), where approxi-
mately equal numbers of multinucleated TRAP-positive cells
were observed, with p-nitrophenyl phosphate, a colorimetric
substrate for TRAP. A twofold increase in TRAP activity
was seen with Arf-null cells compared to that with wild-type
cells (P  0.01) (Fig. 6D), indicating that the Arf/ osteo-
clasts are far more active than their wild-type counterparts
on a per cell basis. In vivo analysis of osteoclast function of
Arf-null mice mimicked our in vitro findings of osteoclast
hyperactivity, as there was an 18% increase in the level of
FIG. 3. Disruption of ARF enhances protein synthesis independent of cellular proliferation. (A) Cells were starved of methionine and cysteine
for 30 min prior to the addition of a [35S]methionine label for the indicated times, followed by lysis, trichloroacetic acid precipitation of proteins,
and liquid scintillation counting. (B) Equal numbers of cells (1  105) were plated in triplicate at day 0 and then were trypsinized and counted
via a hemocytometer at various time points. (C) Cycloheximide (50 g/ml) was added for 10 min prior to lysis and ultracentrifugation of cleared
lysate on 10 to 40% sucrose gradients. The graph shows an A254 of ribosome subunits over increasing sucrose density. (D) Equal-passage MEFs
(1  105) were trypsinized and analyzed by a Coulter Vi-Cell counter for cell volume. (E) Equal-passage MEFs (1 106) were harvested and
analyzed for protein content by a standard colorimetric DC assay. WT, wild type.
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serum TRAP activity over that of the wild type controls (Fig.
6E).
Loss of Arf increases rRNA transcription, rRNA processing,
and ribosome nuclear export. Previous reports have demon-
strated a role for ARF in rRNA processing (37). Furthermore,
our laboratory has previously demonstrated ARF’s inhibitory
activity on the shuttling of NPM (8) and NPM’s nucleolar
cargo, rpL5 and 5S rRNA (46). Additional reports have dem-
onstrated a role for nucleolar ARF in preventing rDNA tran-
scription through both Myc-dependent and -independent
mechanisms (2, 3, 30). Taken together, nucleolar ARF could
prevent all three steps in ribosome biogenesis: transcription,
processing, and export. The loss of Arf had no impact on the
levels of either NPM or rpL5, suggesting that ARF’s effect on
this pathway was not due to altered synthesis and/or destruc-
tion of these proteins (Fig. 7A). Moreover, serial immu-
nodepletion of NPM revealed two distinct pools of ARF: one
that is effectively associated with NPM (Fig. 7B, lane 1) and a
second pool that is free from NPM (Fig. 7B, lane 6). This
implies that ARF’s effects on ribosome biogenesis may not be
relegated to only NPM-dependent processes and is consistent
with the idea that ARF antagonizes rDNA transcription
through other unique, physically interacting proteins. Accord-
ingly, the loss of Arf resulted in a fourfold increase in 47S
rRNA transcription (Fig. 7C), a process thought to be inde-
pendent of direct NPM regulation (as NPM does not localize
to the fibrillar compartment of the nucleolus).
Newly transcribed 47S rRNAs are further processed in the
nucleolus into their mature 28S, 18S, and 5.8S rRNAs (34).
These processes are known to be readily antagonized by over-
expressed ARF (37). To determine the effect of the Arf loss on
these events, newly synthesized 47S rRNAs were followed
through nucleolar processing. rRNA processing was greatly
accentuated in the Arf/ MEFs over a 2-h period (Fig. 7D).
While the wild-type and the Arf-null cells clearly start with
different amounts of 47S rRNA (Fig. 7C), the Arf-null cells are
capable of churning out more processed rRNAs (15-fold more
than the wild type), which is nearly a threefold amplification
over the starting amount of 47S transcripts. This suggests that
while levels of 47S rRNA are certainly permissive for greater
processing of rRNAs, they cannot entirely account for the
sheer magnitude of increases in processed rRNAs observed in
the Arf/ cells.
To determine the precise step at which ARF might influence
rRNA processing, we labeled cells with [methyl-3H]methi-
onine, which labels rRNA, and loaded equal amounts of the
radioactive label to examine processing intermediates after
short time periods of chase with label-free media. We observed
only a modest increase of the 32S rRNA precursors in cells
lacking Arf at early time periods, indicating that ARF may
interfere with the processing steps between the 47S transcript
and the 32S intermediate (Fig. 7E). However, after 2 h of
chase, we saw no differences in the relative amounts of radio-
activity in the final 18S and the 28S products, indicating that
the loss of Arf had no impact on these downstream processing
steps. These results exactly mirror what Sugimoto and col-
leagues observed when they overexpressed ARF, namely, an
accumulation of improperly processed rRNA intermediates
between the 47S and 32S stages (37), albeit to a far lesser
extent in our experiments.
As a final step in ribosome biogenesis, mature ribosome
subunits are exported to the cytosol in a process that we have
previously attributed to NPM-directed nuclear export (27, 46).
The Arf-null MEFs exhibited a more robust (25-fold) nuclear
export of newly processed rRNAs than the wild-type cells did
(Fig. 8A). Again, this extreme difference between the wild-type
and the Arf-null cells was far greater than any previous step in
ribosome biogenesis (e.g., transcription or processing), imply-
ing that each step represents an amplification of the previous
step. This was most evident when the real-time nuclear export
of rRNAs, as monitored by scintillation counting of newly
exported 3H-labeled rRNA, revealed that the absolute rates of
rRNA export were threefold increased in cells lacking Arf (Fig.
8B). Taking these data together, we believe this reflects the
ability of ARF to regulate moment-to-moment steps in ribo-
some biogenesis, such that alterations in ARF levels may pro-
duce robust and rapid responses that effect cytoplasmic ribo-
somal content.
FIG. 4. ARF regulates protein synthesis and ribosome biogene-
sis in vivo. (A) Livers were isolated from three wild-type (WT) and
Arf-null littermates and briefly trypsinized. Cells (5  106) were
immediately cultured in methionine-free medium for 15 min and
then incubated with [35S]methionine for the indicated times. Pro-
teins were trichloroacetic acid precipitated, and labeled proteins
were quantified by liquid scintillation counting. (B) Spleens were
isolated from three wild-type and Arf-null littermates. Cells (1 
107) were immediately harvested, and cytosolic fractions were
loaded onto 7 to 47% sucrose gradients for ultracentrifugation
separation. Graph B shows an A254 of ribosome subunits over in-
creasing sucrose density.
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Myc is not responsible for the rDNA transcription increases
in the Arf/ cells. Previous reports have shown that the c-Myc
transcription factor, in part, localizes to the nucleolus to pos-
itively regulate the transcription of rDNA (15, 16). Moreover,
ARF has been shown to antagonize Myc functions through
direct interactions (30). Thus, we sought to determine whether
basal ARF proteins might be regulating nucleolar Myc to pre-
vent the aberrant transcription of the rDNA loci. We utilized
siRNAs targeting the 3 UTR of c-Myc to successfully knock
down endogenous Myc nearly 20-fold (Fig. 9A). While lower
Myc protein levels greatly reduced 47S rRNA transcripts in
wild-type MEFs, it had little impact on 47S copies in the
Arf/ MEFs (Fig. 9B). While the former result is consistent
with previous studies showing a role for Myc in rDNA tran-
scription (15, 16), the latter result suggests that Myc is not
absolutely required for rDNA transcription in cells lacking
Arf. However, when Myc levels were restored by using an
siRNA-resistant (lacking the targeted 3 UTR sequence)
Myc-ER construct and 4-hydroxytamoxifen treatment (50),
47S transcript levels significantly increased in the Arf-null
MEFs, suggesting that Myc proteins can positively direct
rDNA transcription in the absence of ARF (Fig. 9A and B).
NPM is required for the growth gains seen in the absence of
Arf. Having shown that nearly half of the basal ARF proteins
are bound to NPM in wild-type MEFs (Fig. 7B), we hypothe-
sized that NPM is a critical nucleolar target of basal ARF and
that the loss of Arf resulted in unregulated NPM activities. To
test this hypothesis, we knocked down NPM expression in
MEFs lacking Arf to determine the effects on ribosome bio-
genesis and protein synthesis. Using lentiviruses carrying
shRNAs targeting mouse NPM, we were able to achieve
greater than 90% NPM knockdown efficiency (Fig. 10A). How-
FIG. 5. Acute depletion of p19ARF results in nucleolar, morphological, and functional changes reminiscent of the Arf/ cells. (A) Western
blotting confirmation of the p19ARF knockdown in wild-type (WT) MEFs 96 h postinfection with lentiviral shRNA constructs using antibodies
recognizing -tubulin, NPM, rpL5, p19ARF, and p16INK4a. Expression change (n-fold) is marked under each panel. (B) AgNOR staining of
representative MEFs infected with control (scrambled) or p19ARF-specific shRNA virus. (C) Quantification of AgNOR indices. Left panel shows
the number of AgNORs per nucleus (n 
 100). Right panel shows the total nucleolar area (in m2) per nucleus as determined by histomorpho-
metric analysis (n 
 100). *, P  0.01 (D) Total radioactivity incorporated after [
35S]methionine pulse. Cells were starved of methionine and
cysteine for 30 min prior to the addition of label for the indicated times, followed by lysis, trichloroacetic acid precipitation of proteins, and liquid
scintillation counting. (E) Cycloheximide (50 g/ml) was added for 10 min prior to lysis and ultracentrifugation of cleared lysate on 10 to 40%
sucrose gradients. The graph shows an A254 of ribosome subunits over increasing sucrose density.
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ever, the reduction in NPM protein expression led to a dra-
matic increase in 47S rRNA transcripts in cells that also lacked
Arf (Fig. 10B), indicating that NPM might actually inhibit
rDNA transcription. The increase in 47S rRNA did not result
in a similar increase in rRNA processing. In fact, we observed
a slight but notable accumulation of 32S rRNA for cells lacking
both ARF and NPM (Fig. 10C). We also noticed the appear-
ance of an rRNA species above the 18S rRNA only in the
absence of ARF and NPM, which may be the result of an
additional processing defect (Fig. 10C). Furthermore, nuclear
exportation of processed 18S rRNA was significantly attenu-
ated (55% reduction) in the Arf-null cells lacking NPM (Fig.
10D), demonstrating the requirement for NPM in trafficking
mature rRNAs out of the nucleus and into the cytosol. In
response to decreased ribosome export to the cytosol, the
Arf/ MEFs with reduced NPM expression exhibited signifi-
cantly attenuated protein synthesis rates (Fig. 10E). Thus,
gains in rDNA transcription are not realized in terms of overall
protein synthesis in the absence of NPM. This could be a result
of a ribosome biogenesis feedback loop, where reduced ribo-
some export causes a shift in rDNA transcription to compen-
sate for the lack of cytosolic ribosomes. However, in the ab-
sence of NPM, these ribosomes cannot be properly exported.
To determine whether protein synthesis gains observed with
the absence of Arf were caused by the deregulation of NPM
and were independent of proliferation, we lowered the levels
FIG. 6. Loss of p19ARF has functional consequences on osteoclast biology. (A) BrdU incorporation in the wild-type (WT) and Arf/
macrophages. (B) Representative TRAP staining of equal numbers of BMMs following 3 days of treatment with M-CSF and RANKL reveals an
increase in multinucleated osteoclasts formed from the Arf/ precursors. (C) The graph shows increases in TRAP-positive osteoclasts with greater
than five nuclei derived from the Arf/ bone marrow. *, P 
 0.01. (D) TRAP solution assay of equal numbers of TRAP-positive cells. Cells from
the wild-type (day 4 post-RANKL addition) or the Arf/ (day 3 post-RANKL addition) precursors were lysed and incubated in a colorimetric
assay with p-nitrophenyl phosphate, a substrate for TRAP. The graph shows an A405. *, P
 0.01. (E) Levels of serum TRAP 5b in Arf
/ compared
to that in wild-type mice (P 
 0.03; n 
 5 mice in each group) as measured by ELISA.
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of NPM in maturing osteoclasts. We reasoned that by reducing
NPM expression in osteoclasts, we would mimic a restoration
of ARF activity without the complicating effects of cell cycle
arrest (i.e., osteoclasts are postmitotic) or of ARF binding to
Mdm2 (i.e., a p53 response). This provided us with an exper-
imental system with which to test the hypothesis that a balance
exists between ARF and NPM in determining the ribosome
output from the nucleolus. Lentiviral shRNAs targeting NPM
in BMMs significantly reduced NPM protein expression levels
(Fig. 11A). Concomitant with decreases in NPM expression,
the Arf/ osteoclasts were dramatically reduced in levels of
TRAP staining (Fig. 11B) and activity (Fig. 11C), indicating a
sensitivity of osteoclast differentiation to lower NPM levels.
However, wild-type osteoclasts were far less sensitive to de-
creases in NPM expression, showing no statistically significant
difference in TRAP activity. These data suggest that, in the
absence of Arf, amplified ribosome biogenesis requires a set
amount of NPM (for processing or export) and further impli-
cates NPM as a target of basal ARF proteins in the mainte-
nance of proper ribosome output.
DISCUSSION
While ARF has been long appreciated for its abilities to
positively regulate p53 levels in the cell (22, 29) and serve as a
sensor of hyperproliferative signals (19, 20, 31, 50), the rela-
tively low abundance of ARF in interphase cells implied that
ARF functioned only as a cellular checkpoint against aberrant
growth and proliferation signals. In this manner, only signals
powerful enough to elicit increases in ARF protein expression
would trigger an actual ARF response. This implies that basal
ARF molecules, even at their low levels, must be antagonized
or held in check for the cell to undergo proper cell cycle
progression and cell growth regimens. Teleologically, this
model seems justified, given the genomic organization of the
Ink4a/Arf locus where “leakiness” in p16INK4a or p19ARF
FIG. 7. ARF exerts its effects through the control of rRNA synthesis and processing. (A) Western blotting demonstrates that the Arf/
MEFs do not have alterations in the levels of nucleolar proteins NPM and ribosomal protein L5. (B) Serial NPM immunoprecipitation.
Wild-type cells were lysed and serially immunoprecipitated (five times) with mouse NPM antibodies. The final supernatant was concentrated
and was included as a control for non-NPM binding proteins. (C) Total RNA was collected from equal numbers of asynchronously dividing
cells, and quantitative real-time RT-PCR was performed with a primer specific to the mouse 47S transcript. (D) The wild-type (WT) and
Arf/ cells were pulsed with a [3H]uridine label for 30 min, followed by a chase with label-free medium for the indicated times. Total RNA
was isolated from equal cell numbers, loaded onto formaldehyde-containing agarose gels, and transferred to membranes for fluorography.
(E) Cells were labeled with [methyl-3H]methionine, followed by a chase with medium containing excess unlabeled methionine for the
indicated times. Total RNA was isolated, and equal radioactive counts were loaded onto gels and transferred to membranes for fluorography.
CPM, counts per minute.
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transcription would have dire effects on the growth and sur-
vival of the cell (14). It is widely held that this locus is repressed
in mice and that only under conditions of extreme stress or
oncogenic signaling is the locus transcribed to elicit a growth
and proliferative arrest phenotype (51). Here, we provide ev-
idence that the physiologically low level of ARF has a regula-
tory role in nucleolar function and ribosome biogenesis. In-
deed, as early as 4 days post-ARF knockdown by lentiviral
shRNA infection, we observed changes in nucleolar morphol-
ogy and function that are reminiscent of data from the Arf/
embryonic cells. This strongly supports the hypothesis that
basal ARF consistently monitors and dynamically alters the
nucleolar growth/suppression pathway on a day-to-day basis.
We would now argue that basal ARF proteins must be main-
tained at some steady-state level to provide constant surveil-
lance of nucleolar function. Given the great energy demands of
the nucleolus (ribosome biogenesis and protein synthesis ac-
count for nearly 50% of the cell’s energy), dysfunctional nu-
cleolar processes may need to be adjusted at a moment’s notice
(26). In support of this contention, a recent report (33) dem-
onstrated that selective disruption of the nucleolus by either
UV radiation or a number of “stress” responses induced cell
cycle arrest and markedly enhanced p53 stability. While we did
not observe any gross disruption of nucleoli in cells either
lacking or overexpressing ARF, we did observe numerous
qualitative changes in the size and number of nucleoli in cells
lacking Arf. This would suggest that basal ARF might play a
vital role in determining the protein composition of nucleoli,
acting to prevent the release of specific ribosomal proteins
from the nucleolus or to prohibit the entrance of unwanted
(potentially oncogenic) nuclear proteins into the nucleolus.
In the past few years, numerous p53-independent functions
have been ascribed to ARF (35). We found that nearly half of
the basal ARF in the cell is in a complex with NPM, a protein
previously shown to interact with human and mouse ARF
proteins (4, 8, 21). While much of the work concerning the
ARF-NPM interaction has focused on the ability of each pro-
tein to antagonize the function of the other (4, 8, 21, 24, 46),
our findings suggest that the baseline interaction functions to
maintain a controlled level of ribosome biogenesis. We pro-
pose a model where basal ARF antagonizes a small pool of
NPM, either directly or enzymatically (8, 38), and thereby
constantly limits ribosome output from the nucleolus. Impor-
tantly, levels of NPM did not change in the absence of ARF,
but rather NPM activity was greatly increased as measured by
its ability to promote ribosome nuclear export. Consistent with
this model, the knockdown of basal NPM proteins resulted in
dramatic reductions in protein production independent of cell
proliferation, again underscoring the need for a consistent
level of “ARF-free” NPM to promote ribosome synthesis.
While the mechanism and nature of such inhibition are still
unclear, our data are consistent with a “thermostat” function
for ARF, in that small changes in the abundance of ARF cause
FIG. 8. Nucleocytoplasmic shuttling of newly synthesized ribo-
somes is enhanced in the absence of Arf. (A) Equal numbers of cells
were pulsed with [methyl-3H]methionine and chased with unlabeled
methionine-containing medium for the indicated times. Total RNA
was isolated from nuclear (N) and cytoplasmic (C) fractions and sub-
jected to fluorography. (B) Cytoplasmic fractions from the indicated
times were also subjected to liquid scintillation counting to obtain a
quantitative estimate of total cytoplasmic rRNA. Inset, scatter plot of
data presented in panel B with best-fit lines to indicate the velocity of
export. m 
 slope. WT, wild type.
FIG. 9. Myc is not required for the enhanced rDNA transcription
of the Arf-null MEFs. the Arf/ MEFs (2  106) transduced with
siLuc control siRNAs or Myc siRNAs in the absence or presence of
Myc-ER expressing retroviruses and 4-hyrodxytamoxifen were har-
vested and (A) immunoblotted with antibodies recognizing c-Myc or
-tubulin. (B) RNA was isolated from the above cells and real-time
PCR using 47S rRNA probes was performed in triplicate. WT, wild
type.
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its binding partners to either dampen or enhance ribosome
synthesis and export and, ultimately, lead to global changes in
protein synthesis. It is apparent from our data that basal ARF
can act in three distinct steps: (i) rDNA transcription, (ii)
rRNA processing, and (iii) rRNA nuclear export.
While NPM has been ascribed roles in both rRNA process-
ing and nuclear export (36, 47), we are uncertain of its ability
to regulate rDNA transcription. In fact, NPM and ARF are
both found in the granular region of the nucleolus, relatively
far removed from the sites of nucleolar rDNA transcription
(8). However, we did observe significantly enhanced transcrip-
tion of 47S rRNA in the absence of Arf, implying that ARF
proteins might regulate this process either directly or indi-
rectly. This is not unprecedented, given recent findings that
human ARF interacts with topoisomerase I to inhibit rDNA
transcription (3, 23). Additionally, nearly half of the basal ARF
protein is not bound to NPM, and we therefore cannot rule out
the possibility that this pool of ARF is bound to proteins
involved in rDNA transcription.
We suggest that ARF is expressed at a low level in inter-
phase cells to ensure that proper growth control is achieved.
This would serve to keep the cell in metabolic check, prevent-
FIG. 10. NPM is required for ribosome gains in the absence of Arf. The Arf/ MEFs (2  106) infected with lentiviruses encoding scrambled
or NPM shRNAs were (A) lysed and immunoblotted with antibodies recognizing NPM and -tubulin; (B) lysed and RNA isolated for real-time
PCR using 47S rRNA probes; (C) labeled with [methyl-3H]methionine, followed by a chase with medium containing excess unlabeled methionine
for the indicated times, isolation of total RNA and equal radioactive counts, loading onto gels, and transfer to membranes for fluorography;
(D) fractionated into nuclear (N) and cytosolic (C) lysates and immunoblotted with lamin A/C and SOD or Northern blotted with probes
recognizing the 18S rRNA; or (E) starved of methionine and cysteine for 30 min prior to the addition of label for the indicated times, followed
by lysis, trichloroacetic acid precipitation of proteins, and liquid scintillation counting. *, P  0.01.
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ing the cell from wasting energy on unnecessary protein syn-
thesis. Disruption of this exquisite basal ARF control would
then have a twofold effect: (i) cells would produce far too many
ribosomes, resulting in tremendous gains in protein synthesis,
and (ii) the resultant cells would be highly susceptible to on-
cogenic signals. This setting would seem to provide a selective
advantage to premalignant cells by ramping up their growth
and, in the presence of appropriate signals, their proliferation.
In support of this hypothesis, a recent study on the methylation
of key loci involved in colorectal carcinogenesis demonstrated
that 32% of the adenomas (premalignant lesions) isolated
from patients with sporadic colorectal cancer demonstrated
abnormalities at the Arf locus (11). Our findings represent a
novel and important role for basal ARF in maintaining protein
synthetic homeostasis in nonmalignant cells. While NPM is
certainly required for much of the ribosome biogenesis gains
observed for Arf-deficient cells, other interesting nucleolar tar-
gets of basal ARF must certainly exist. Precise details of how
they may be affected remain elusive. Understanding the nucle-
olar integration of disparate requirements for proliferation,
growth, and ribosome biogenesis will deepen our knowledge of
how proteins like ARF adapted from regulators of cellular
homeostasis to bona fide tumor suppressors.
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